Home > Insider Trading > Filing (0001225208-20-007337)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099800	Edwards Lifesciences Corp	EW	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	364316614

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1196661	Jr E Donald Bobo	One Edwards Way Irvine CA 92614	Cvp,Strategy/Corp Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-07	1,625	$0.00	22,447	No	4	A	Direct
Common Stock	Acquisiton	2020-05-08	5,372	$35.79	27,819	No	4	M	Direct
Common Stock	Disposition	2020-05-08	5,372	$220.94	22,447	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Acquire)	Acquisiton	2020-05-07	16,300	$0.00	16,300	$218.04
Common Stock	Performance Rights	Acquisiton	2020-05-07	2,025	$0.00	2,025	$0.00
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2020-05-08	5,372	$0.00	5,372	$35.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,300	2020-06-07	2027-05-06	No	4	A	Direct
2,025	2023-05-07	2027-05-06	No	4	A	Direct
0	2014-05-14	2020-05-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,673	Indirect	401(k)
Common Stock	176	Indirect	By Son
Common Stock	41,232	Indirect	By Trust

Footnotes

These restricted stock units were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.
Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator.
These options were granted on May 7, 2020 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.
Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 7, 2020 and scheduled to vest on May 7, 2023. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.